Steris adds X-ray processing in Chonburi, Thailand expansion
02 Apr 2024
Radiation Therapy
NEWS RELEASE: STERIS announces completed expansion of Chonburi, Thailand facility now includes X-ray processing
Supports medical device manufacturing with additional radiation processing capacity
Complements existing EO, E-beam and gamma services in Asia
As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce the completed expansion of its existing Chonburi I, Thailand facility now includes X-ray processing. The addition of X-ray processing complements the existing gamma irradiation services offered at the Chonburi I site, as well as the gamma services at the Chonburi II facility.
The expansion of the Chonburi I, Thailand facility furthers our commitment of ensuring patient safety through a technology-neutral service offering that includes radiation and gas processing options, now and well into the future.
In addition to the Chonburi facilities, we support medical device manufacturing in Asia through our electron beam, ethylene oxide, and gamma processing sterilization services in Kuala Ketil, Kulim, Port Klang, and Rawang, Malaysia; and Suzhou, China.
Increased demand in medical device manufacturing has accelerated our plans for global expansion. The addition of accelerator-based radiation processing options throughout our global network allows us to support Customers with both routine services and processing redundancy.
About STERIS
STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare, life sciences and dental products and services. For more information, visit .
The opinions expressed in this news release are the author’s only and do not necessarily reflect those of Medical Design & Outsourcing or its employees.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.